Long Island University
Brooklyn, New York, 11201, United States
NCT Number: NCT04829006
The investigators aim at testing the efficacy of an app to measure sentence intelligibility in noise in speakers with Parkinson's disease and in healthy controls.
Looking for future studies?
Notify Me30 year–85 year
All sexes
Interventional
Not applicable
Brooklyn, New York, 11201, United States
Close to 90% of people with Parkinson's disease develop voice problems during the course of the disease. These problems lead to reduced intelligibility, which entails a subsequent reduction in social participation and overall quality of life. The current study will focus on developing and pilot-testing an app to measure the intelligibility of people with PD and of healthy controls. In order to test the app's efficacy, speakers will read a set of 50 sentences that will be embedded in noise for measurement purposes. A group of listeners will also transcribe the spoken sentences to correlate their performance to that of the app. The ultimate purpose of this investigation is to improve self-monitoring and self-sufficiency in people with PD. The study is expected to last 12 months.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Speakers with PD:
Inclusion criteria
Exclusion criteria
Healthy controls:
Inclusion criteria
Exclusion criteria
Listeners:
Inclusion criteria
Exclusion criteria
The aim of the current investigation is to test the efficacy of an app to measure sentence intelligibility in noise in speakers with Parkinson's disease and in healthy controls.
Time frame: 30 minutes
Percent of words correctly transcribed
Long Island University
Other
Automatic Assessment of Intelligibility in Individuals With Parkinson's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07599696
Articulation Disorders, Atypical Parkinsonism
East Lansing, Michigan, United States
View Trial DetailsNCT05807373
Articulation Disorders, Autonomic Nervous System Diseases
Bordeaux, France
View Trial DetailsNCT05754086
Articulation Disorders, Basal Ganglia Diseases
Tallahassee, Florida, United States
View Trial DetailsNCT04966689
Basal Ganglia Diseases, Brain Diseases
Tehran, Iran
View Trial Details